Tissue-engineered heart valves

Physiological Research

Volumn 58, Issue SUPPL.2, 2009, Pages 141-150

  Filova E ^a,b   Straka, F ^a,b,c   Mirejovsky T ^c   Masin J ^c   Bačáková, Lucie ^a,b  

^a Center for Cardiovascular Research   (Czech Republic)

^b INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^c INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Bioartificial heart valve; Mesenchymal stem cells; Nanofibrous scaffolds; Pulse flow bioreactor; Tissue engineering; Valve interstitial cells

Indexed keywords

BIOMATERIAL;

ANIMAL; BIOPROSTHESIS; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HUMAN; INSTRUMENTATION; PROSTHESIS; REVIEW; TISSUE CULTURE TECHNIQUE; TISSUE ENGINEERING;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIOPROSTHESIS; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PROSTHESIS DESIGN; TISSUE CULTURE TECHNIQUES; TISSUE ENGINEERING;

EID: 77949495249     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (119)

1. AIKAWA EP, WHITTAKER P, FARBER M, MENDELSON K, PADERA R, SCHOEN F: Human semilunar cardiac valve remodeling by activated cells from fetus to adult: Implications for postnatal adaptation, valve pathology and tissue engineering. Circulation 113: 1344-1352, 2006.
2. ASCHERMANN M: Kardiologie. (in Czech) Galen, Prague, 2004, p. 1322.
3. BAGUNEID MS, SEIFALIAN AM, SALACINSKI HJ, MURRAY D, HAMILTON G, WALKER MG: Tissue engineering of blood vessels. Br J Surg 93: 282-290, 2006.
4. BENSE CA, WOODHOUSE KA: Plasmin degradation of fibrin coatings on synthetic polymer substrates. J Biomed Mater Res 46: 305-314, 1999.
5. BINI E, FOO CW, HUANG J, KARAGEORGIOU V, KITCHEL B, KAPLAN DL: RGD-functionalized bioengineered spider dragline silk biomaterial. Biomacromolecules 7: 3139-3145, 2006.
6. BJÖRK VO: The history of the Björk-Shiley tilting disc valve. Med Instrum 11: 80-81, 1977.
7. BOENHOEFFER P, BOUDJEMLINE Y, SALIBA Z, MECKX J, AGGOUN Y, BONNET D, ACAR P, LE BIDOIS J, SIDI D, KANACHER J: Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonaryartery prosthetic conduit with valve dysfunction. Lancet 356: 1403-1405, 2000.
8. BOOTH C, KOROSSIS SA, WILCOX HE, WATTERSON KG, KEARNEY JN, FISHER J, INGHAM E: Tissue engineering of cardiac valve prostheses. I. Development and histological characterization of an acellular porcine scaffold. J Heart Valve Dis 11: 457-462, 2002.
9. BROWN MA, IYER RK, RADISIC M: Pulsatile perfusion bioreactor for cardiac tissue engineering. Biotechnol Prog 24: 907-920, 2008.
10. BUNNELL BA, FLAAT M, GAGLIARDI C, PATEL B, RIPOLL C: Adipose-derived stem cells: isolation, expansion and differentiation. Methods 45: 115-120, 2008.
11. BUTCHER JT, PENROD AM, GARCIA AJ, NEREM RM: Unique morphology and focal adhesion development of valvular endothelial cells in static and fluid flow environments. Arterioscler Thromb Vasc Biol 24: 1429-1434, 2004.
12. BUTCHER JT, TRESSEL S, JOHNSON T, TURNER D, SORESCU G, JO H, NEREM RM: Transcriptional profiles of valvular and vascular endothelial cells reveal phenotypic differences: Influence of shear stress. Arterioscler Thromb Vasc Biol 26: 69-77, 2005.
13. BUTCHER JT, SIMMONS CA, WARNOCK JN: Mechanobiology of the aortic heart valve. J Heart Valve Dis 17: 62-73, 2008.
14. CHESTER AH, MISFELD M, YACOUB MH: Receptor-mediated contraction of aortic valve leaflets. J Heart Valve Dis 9: 250-255, 2000.
15. CHLUPÁČ J, FILOVÁ E, RIEDEL T, BRYNDA E, REMY-ZOLGHADRI M, BAREILLE R, FERNANDEZ P, DACULSI R, BORDENAVE L, BAČÁKOVÁ L: Human endothelium on vascular prostheses modified by extracellular matrix proteins in a flow experiment. Eng Biomater 58-60: 10-13, 2006.
16. CHLUPÁČ J, FILOVÁ E, RIEDEL T, BRYNDA E, PAMULA E, REMY-ZOLGHADRI M, BAREILLE R, FERNANDEZ P, DACULSI R, BURGET C, BORDENAVE L, BAČÁKOVÁ L: Endothelial cells seeded on protein multilayer assemblies under shear stress. Physiol Res 57: 77P, 2008.
17. CIMINI M, ROGERS KA, BOUGHNER DR: Smoothelin-positive cells in human and porcine semilunar valves. Histochem Cell Biol 120: 307-317, 2003.
18. CLARK RAF: Fibrin and wound healing. Ann NY Acad Sci 936: 355-367, 2001.
19. CONCHA M, ARANDA PJ, CASARES J, MERINO C, ALADOS P, MUNOZ I, GONZALES JR, RIBES R, VILLALBA R: The Ross procedure. J Card Surg 19: 401-409, 2004.
20. CRIBIER A, ELTCHANINOFF H, BASH A, BORENSTEIN N, TRON C, BAUER F, DERUMEAUX G, ANSELME F, LABORDE F, LEON MB: Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106: 3006-3008, 2002.
21. CUMMINGS CL, GAWLITTA D, NEREM RM, STEGEMANN JP: Properties of engineered vascular constructs made from collagen, fibrin, and collagen-fibrin mixtures. Biomaterials 25: 3699-3706, 2004.
22. DAAMEN WF, VEERKAMP JH, VAN HEST JCM, VAN KUPPEVELT TH: Elastin as a biomaterial for tissue engineering. Biomaterials 28: 4378-4398, 2007.
23. DANIŠOVIČ L, VARGA I, POLÁK S, ULIČNÁ M, BOHMER D, VOJTASSAK J: Morphology of in vitro expanded human muscle-derived stem cells. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 152: 235-238, 2008.
24. DECK JD: Endothelial cell orientation on aortic valve leaflets. Cardiovasc Res 20: 760-767, 1986.
25. DONG X, WEI X, YI W, GU C, KANG X, LIU Y, LI Q, YI D: RGD-modified acellular bovine pericardium as a bioprosthetic scaffold for tissue engineering. J Mater Sci Mater Med 2009, Jun 9 [Epub ahead of print].
26. DVIR T, LEVY O, SHACHAR M, GRANOT Y, COHEN S: Activation of the ERK1/2 cascade via pulsatile interstitial fluid flow promotes cardiac tissue assembly. Tissue Eng 13: 2185-2193, 2007.
27. EISENBERG LM, MARKWALD RR: Molecular regulation of atrioventricular valvuloseptal morphogenesis. Circ Res 77: 1-6, 1995.
28. EMERY RW, NICOLOFF DM: St. Jude Medical cardiac valve prosthesis: in vitro studies. J Thorac Cardiovasc Surg 78: 269-276, 1979.
29. EMERY RW, METTLER E, NICOLOFF DM: A new cardiac prosthesis: the St. Jude Medical cardiac valve: in vivo results. Circulation 60: 48-54, 1979.
30. ENGELMAYR GC Jr, SACKS MS: Prediction of extracellular matrix stiffness in engineered heart valve tissues based on nonwoven scaffolds. Biomechan Model Mechanobiol 7: 309-321, 2008.
31. ENGELMAYR GC Jr, SALES VL, MAYER JE Jr, SACKS MS: Cyclic flexure and laminar flow synergistically accelerate mesenchymal stem cell-mediated engineered tissue formation: Implications for engineered valve tissues. Biomaterials 27: 6083-6095, 2006.
32. EZZELARAB M, YAMADA K; COOPER DKC; SACHS DH: Pig-to-nonhuman primate organ xenotransplantation. Curr Opin Organ Transplant 10: 234-239, 2005.
33. FARALLI JA, SCHWINN MK, GONZALES JM Jr, FILLA MS, PETERS DM: Functional properties of fibronectin in the trabecular meshwork. Exp Eye Res 88: 689-693, 2009.
34. FAYET C, BENDECK MP, GOTLIEB AI: Cardiac valve interstitial cells secrete fibronectin and form fibrillar adhesions in response to injury. Cardiovasc Pathol 16: 203-211, 2007.
35. FILOVÁ E, BRYNDA E, RIEDEL T, BAČÁKOVÁ L, CHLUPÁČ J, LISÁ V, HOUSKA M, DYR JE: Vascular endothelial cells on two- and three-dimensional fibrin assemblies for biomaterial coatings. J Biomed Mater Res A 90: 55-69, 2009a.
36. FILOVÁ E, STRAKA F, BAČÁKOVÁ L, MUNZAROVÁ M, SVOBODOVÁ J: Growth of valve interstitial cells on aligned and randomly oriented electrospun nanofibres. Joint meeting of the Society for Heart Valve Disease & Heart Valve Society of America, Berlin, p. 379, 2009b.
37. FLANAGAN TC, WILKINS B, BLACK A, JOCKENHOEVEL S, SMITH TJ, PANDIT AS: A collagenglycosaminoglycan co-culture model for heart valve tissue engineering applications. Biomaterials 27: 2233-2246, 2006.
38. FLANAGAN TC, CORNELISSEN C, KOCH S, TSCHOEKE B, SACHWEH S, SCHMITZ-RODE T, JOCKENHOEVEL S: The in vitro development of autologous fibrin-based tissue-engineered valves through optimised dynamic conditioning. Biomaterials 28: 3388-3397, 2007.
39. FORBESS JM, SHAH AS, ST LOUIS JD, JAGGERS JJ, UNGERLEIDER RM: Cryopreserved homografts in the pulmonary position: determinants of durability. Ann Thorac Surg 71: 54-60, 2001.
40. GELAIN F, HORII A, ZHANG S: Designer self-assembling peptide scaffolds for 3-D tissue cell cultures and regenerative medicine. Macromol Biosci 7: 544-551, 2007.
41. GOJO S, GOJO N, TAKEDA Y, MORI T, ABE H, KYO S, HATA J, UMEZAWA A: In vivo cardiovasculogenesis by direct injection of isolated adult mesenchymal stem cells. Exp Cell Res 288: 51-59, 2003.
42. GRASSL ED, OEGEMA TR, TRANQUILLO RT: Fibrin as an alternative biopolymer to type-I collagen for the fabrication of a media equivalent. J Biomed Mater Res 60: 607-612, 2002.
43. GRASSL ED, OEGEMA TR, TRANQUILLO RT: A fibrin-based arterial media equivalent. J Biomed Mater Res A 66: 550-561, 2003.
44. HOCKING DC, KOWALSKI K: A cryptic fragment from fibronectin's III1 module localizes to lipid rafts and stimulates cell growth and contractility. J Cell Biol 158: 175-184, 2002.
45. HOERSTRUP SP, KADNER A, BREYMANN C, MAURU CF, GUENTER CI, SODIAN R, VISJAGER JF, ZUND G, TURINA MI: Living, autologous pulmonary artery conduits tissue engineered from human umbilical cord cells. Ann Thorac Surg 74: 46-52, 2002.
46. HORBETT TA: Principles underlying the role of adsorbed plasma proteins in blood interactions with foreign materials. Cardiovasc Pathol 2: 137S-148S, 1993.
47. HUANG H, ZHOU YM, ISHIBASHI-UEDA H, TAKAMIZAWA K, ANDO J, KANDA K, YAKU H, NAKAYAMA Y: In vitro maturation of "biotube" vascular grafts induced by a 2-day pulsatile flow loading. J Biomed Mater Res B Appl Biomater 91: 320-328, 2009.
48. HUFNAGEL CA, VILLEGAS PD, NAHAS H: Experiences with new types of aortic valvular prostheses. Ann Surg 147: 636-644, 1958.
49. IOP L, RENIER V, NASO F, PICCOLI M, BONETTI A, GANDAGLIA A, POZZOBON M, PAOLIN A, ORTOLANI F, MARCHINI M, SPINA M, DE COPPI P, SARTORE S, GEROSA G: The influence of heart valve leaflet matrix characteristics on the interaction between human mesenchymal stem cells and decellularized scaffolds. Biomaterials 30: 4104-4116, 2009.
50. ITO S, ISHIMARU S, WILSON SE: Inhibitory effect of type I collagen gel containing α-elastin on proliferation and migration of vascular smooth muscle and endothelial cells. Cardiovasc Surg 5: 176-183, 1997.
51. JACKSON MR: Fibrin sealant in surgical practice: an overview. Am J Surg 182: 1-7, 2001.
52. JOCKENHOEVEL S, ZUND G, HOERSTRUP SP, CHALABI K, SACHWEH JS, DEMIRCAN L, MESSMER BJ, TURIN A: Fibrin gel - advantages of a new scaffold in cardiovascular tissue engineering. Eur J Cardio-Thorac Surg 19: 424-430, 2001.
53. KARNIK SK, BROOKE BS, BAYES-GENIS A, SORENSEN L, WYTHE JD, SCHWARTZ RS, KEATING MT, LI DY: A critical role of elastin signaling in vascular morphogenesis and disease. Development 130: 411-423, 2003.
54. KHEW ST, YANG QJ, TONG YW: Enzymatically crosslinked collagen-mimetic dendrimers that promote integrintargeted cell adhesion. Biomaterials 29: 3034-3045, 2008.
55. KILNER PJ, YANG GZ, WILKES AJ, MOHIADDIN RH, FIRMIN DN, YACOUB MH: Asymmetric redirection of flow through the heart. Nature 404: 759-761, 2000.
56. KNIGHT RL WILCOX HE, KOROSSIS SA, FISHER J, INGHAM E: The use of acellular matrices for the tissue engineering of cardiac valves. Proc Inst Mech Eng H 222: 129-143, 2008.
57. KOENIG AL, GAMBILLARA V, GRAINGER DW: Correlating fibronectin adsorption with endothelial cell adhesion and signaling on polymer substrates. J Biomed Mater Res A 64: 20-37, 2003.
58. KOROSSIS SA, FISHER J, INGHAM E: Cardiac valve replacement: A bioengineering approach. Biomed Mater Eng 10: 83-124, 2000.
59. KRAMMER A, CRAIG D, THOMAS WE, SCHULTEN K, VOGEL V: A structural model for force regulated integrin binding to fibronectin's RGD-synergy site. Matrix Biol 21: 139-147, 2002.
60. KU CH, JOHNSON PH, BATTEN P, SARATHCHANDRA P. CHAMBRES RC, TAYLOR PM, YACOUB MH, CHESTER AH: Collagen synthesis by mesenchymal stem cells and aortic valve interstitial cells in response to mechanical stretch. Cardiovasc Res 71: 548-556, 2006.
61. KYLE S, AGGELI A, INGHAM E, MCPHERSON MJ: Production of self-assembling biomaterials for tissue engineering. Trends Biotechnol 27: 423-433, 2009.
62. LEE CH, SINGLA A, LEE Y: Biomedical applications of collagen. Int J Pharm 221: 1-22, 2001.
63. LAI PH, CHANG Y, CHEN SC, WANG CC, LIANG HC, CHANG WC, SUNG HW: Acellular biological tissues containing inherent glycosaminoglycans for loading basic fibroblast growth factor promote angiogenesis and tissue regeneration. Tissue Eng. 12: 2499-2508, 2006.
64. LI YS, HAGA JH, CHIEN S: Molecular basis of the effect of shear stress on vascular endothelial cells. J Biomech 38: 1949-1971, 2005.
65. LICHTENBERG A, TUDORACHE I, CEBOTARI S, SUPRUNOV M, TUDORACHE G, GOERLER H, PARK JK, HILFIKER-KLEINER D, RINGES-LICHTENBERG S, KARCK M, BRANDES G, HILFIKER A, HAVERICH A: Preclinical testing of tissue-engineered heart valves re-endothelialized under simulated physiological conditions. Circulation 114 (1 Suppl): I-559-I-565, 2006.
66. LIU SQ, TIECHE C, ALKEMA PK: Neointimal formation on vascular lamina and collagen matrix scaffolds implanted in the rat aortae. Biomaterials 25: 1869-1882, 2004.
67. LIU Y, YANAI R, LU Y, KIMURA K, NISHIDA T: Promotion by fibronectin of collagen gel contraction mediated by human corneal fibroblasts. Exp Eye Res 83: 1196-1204, 2006.
68. LO D, VESELY I: Biaxial strain analysis of the porcine aortic valve. Ann Thorac Surg 60: S374-S378, 1995.
69. MARION NW, MAO JJ: Mesenchymal stem cells and tissue engineering. Methods Enzymol 420: 339-361, 2006.
70. MASTERS KS, SHAH DN, LEINWAND LA, ANSETH KS: Crosslinked hyaluronan scaffolds as a biologically active carrier for valvular interstitial cells. Biomaterials 26: 2517-2525, 2005.
71. MENDELSON K, SCHOEN FJ: Heart valve tissue engineering: concepts, approaches, progress, and challenges. Ann Biomed Eng 34: 1799-1819, 2006.
72. MERRYMAN WD, YOUN I, LUKOFF HD, KRUEGER PM, GUILAK F, HOPKINS RA, SACKS MS: Correlation between heart valve interstitial cell stiffness and transvalvular pressure: implications for collagen biosynthesis. Am J Physiol 290: H224-H231, 2006.
73. MIDWOOD KS, WILLIAMS LV, SCHWARZBAUER JE: Tissue repair and the dynamics of the extracellular matrix. Int J Biochem Cell Biol 36: 1031-1037, 2004.
74. MOL A, DRIESSEN NJB, RUTTEN MC, HOERSTRUP SP, BOUTEN CVC, BAAIJENS PT: Tissue engineering of human heart valve leaflets: A novel bioreactor for a strain-based conditioning approach. Ann Biomed Eng 33: 1778-1788, 2005.
75. NAKAYAMA Y, YAMANAMI M, YAHATA Y, TAJIKAWA T, OHBA K, WATANABE T, KANDA K, YAKU H: Preparation of a completely autologous trileaflet valve-shaped construct by in-body tissue architecture technology. J Biomed Mater Res B Appl Biomater 91: 813-818, 2009.
76. PAMULA E, BAČÁKOVÁ L, FILOVÁ E, BUCZYNSKA J, DOBRZYNSKI P, NOSKOVÁ L, GRAUSOVÁ L: The influence of pore size on colonization of poly(L-lactide-glycolide) scaffolds with human osteoblast-like MG 63 cells in vitro. J Mater Sci Mater Med 19: 425-435, 2008.
77. PAMULA E, FILOVÁ E, BAČÁKOVÁ L, LISÁ V, ADAMCZYK D: Resorbable polymeric scaffolds for bone tissue engineering: The influence of their microstructure on the growth of human osteoblast-like MG 63 cells. J Biomed Mater Res A, 89A: 432-443, 2009.
78. POPELOVÁ J, BENEŠOVÁ M, BRTKO M, ČERNÝ Š, KRUPIČKA J, ČERBÁK R, DOMINIK J, MAREK T: Recommended procedures for the diagnostics and therapy of heart valve defects in adults. Cor Vasa 49 (Suppl): 6-45, 2007.
79. PŘÁDNÝ M, MICHÁLEK J, LESNÝ P, HEJČL A, VACÍK J: Macroporous hydrogels based on 2-hydroxyethyl methacrylate. Part 5. Hydrolytically degradable materials. J Mater Sci Mater Med 17: 1357-1364, 2006.
80. RAMAMURTHI A, VESELY I. Evaluation of matrix-synthesis potential of crosslinked hyaluronan gels for tissue engineering of aortic heart valves: Biomaterials 26: 999-1010, 2005.
81. RIEDEL T, BRYNDA E, DYR JE, HOUSKA M: Controlled preparation of thin fibrin films immobilized at solid surfaces. J Biomed Mater Res A 88: 437-447, 2009.
82. RUEL J, LACHANCE G: A new bioreactor for the development of tissue-engineered heart valves. Ann Biomed Eng 37: 674-681, 2009.
83. SCHLEICHER M, WENDEL HP, FRITZE O, STOCK U: In vivo tissue engineering of heart valves: evolution of a novel concept. Regen Med 4: 613-619, 2009.
84. SCHMIDT D, ACHERMANN J, ODERMATT B, GENONI M, ZUND G, HOERSTRUP SP: Cryopreserved amniotic fluid-derived cells: a lifelong autologous fetal stem cell source for heart valve tissue engineering. J Heart Valve Dis 17: 446-455, 2008.
85. SCHOEN FJ: Evolving concepts of cardiac valve dynamics. The continuum of development, functional structure pathobiology and tissue engineering. Circulation 118: 1864-1880, 2008.
86. SCHURCH WT, SEEMAYER TA, GABBIANI G: The myofibroblast: a quarter century after its discovery. Am J Surg Pathol 22: 141-147, 1998.
87. SCOTT M, VESELY I: Morphology of porcine aortic valve cusp elastin. J Heart Valve Dis 5: 464-471, 1996.
88. SEEBURGER J, GROESDONK H, BORGER MA, MERK D, ENDER J, FALK V, MOHR FW, DOLL N: Quadruple valve replacement for acute endocarditis. J Thorac Cardiovasc Surg 137: 1564-1565, 2009.
89. SEEGER JM, KLINGMAN N: Improved in vivo endothelialization of prosthetic grafts by surface modification with fibronectin. J Vasc Surg 8: 476-482, 1988.
90. SENTHILNATHAN V, TREASURE T, GRUNKEMEIER G, STARR A: Heart valves: which is the best choice? Cardiovasc Surg 7: 393-397, 1999
91. SHIH YRV, CHEN CN, TSAI SW, WANG YJ, LEE OK: Growth of mesenchymal stem cells on electrospun type I collagen nanofibers. Stem Cells 24: 2391-2397, 2006.
92. SIMON P, KASIMIR MT, SEEBACHER G, WEIGEL G, ULLRICH R, SALZER-MUHAR U, RIEDER E, WOLNER E: Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J Cardiothorac Surg. 23: 1002-1006, 2003.
93. SIMMONS CA, GRANT GR, MANDUCHI E, DAVIES PF: Spatial heterogeneity of endothelial phenotypes correlates with side-specific vulnerability to calcification in normal porcine aortic valves. Circ Res 96: 792-799, 2005.
94. SODIAN R, HOERSTRUP SP, SPERLING JS, DAEBRITZ S, MARTIN DP, MORAN AM, KIM BS, SCHOEN F, VACANTI JP, MAYER JE: Early in vivo experience with tissue-engineered trileaflet heart valves. Circulation 102 (Suppl III): III-22-III-29, 2000.
95. STARR A: The Starr-Edwards valve. J Am Coll Cardiol 6: 899-903, 1985.
96. STRAKA F, FILOVÁ E, CHLUPÁČ J, BAČÁKOVÁ L, PIRK J: Bilayer of vascular smooth muscle cells (SMC) and endothelial cells (EC) on a nanofibre mesh in a pulse Bioreactor. Joint meeting of the Society for Heart Valve Disease & Heart Valve Society of America, Berlin, 2009, p. 380.
97. SUTHERLAND FWH, PERRY TE, YU Y, SHERWOOD MC, RABKIN E, MASUDA Y, GARCIA GA, MCLELLAN DL, ENGELMAYR GC Jr, SACKS MS, SCHOEN FJ, MAYER JE Jr: From stem cells to viable autologous semilunar heart valve. Circulation 111: 2783-2791, 2005.
98. SYEDAIN ZH, WEINBERG JS, TRANQUILLO RT: Cyclic distension of fibrin-based tissue constructs: Evidence of adaptation during growth of engineered connective tissue. Proc Natl Acad Sci USA 105: 6537-6542, 2008.
99. TAYLOR PM, BATTEN P, BRAND NJ, THOMAS PS, YACOUB MH: The cardiac valve interstitial cells. Int J Biochem Cell Biol 35: 113-118, 2003.
100. TAYLOR PM, SACHLOS E, DREGER SA, CHESTER AH, CZERNUSZKA JT, YACOUB MH: Interaction of human valve interstitial cells with collagen matrix manufactured using rapid prototyping. Biomaterials 27: 2733-2737, 2006.
101. TEDDER ME, LIAO J, WEED B, STABLER C, ZHANG H, SIMIONESCU A, SIMIONESCU DT: Stabilized collagen scaffolds for heart valve tissue engineering. Tissue Eng Part A 15: 1257-1268, 2009.
102. TULLA M, PENTIKAINEN OT, VIITASALO T, KAPYLA J, IMPOLA U, NYKVIST P, NISSNEN L, JOHNSON MS, HEINO J: Selective binding of collagen subtypes by integrin alpha 1I, alpha 2I, and alpha 10I domains. J Biol Chem 276: 48206-48212, 2001.
103. VESELY I: Heart valve tissue engineering. Circ Res 97: 743-755, 2005.
104. VESELY I, BOUGHNER D: Analysis of the bending behaviour of porcine xenograft leaflet and of neutral aortic valve material: bending stiffness, neutral axis and shear measurements. J Biomech 22: 655-671, 1989.
105. WALPOTH BH, ZAMMARETTI P, CIKIRIKCIOGLU M, KHABIRI E, DJEBAILI MK, PACHE JC, TILLE JC, AGGOUN Y, MOREL D, KALANGOS A, HUBBELL JA, ZISCH AH: Enhanced intimal thickening of expanded polytetrafluoroethylene grafts coated with fibrin or fibrin-releasing vascular endothelial growth factor in the pig carotid artery interposition model. J Thorac Cardiovasc Surg 133: 1163-1170, 2007.
106. WEI HJ, LIANG HC, LEE MH, HUANG YC, CHANG Y, SUNG HW: Construction of varying porous structures in acellular bovine pericardia as a tissue-engineering extracellular matrix. Biomaterials 26: 1905-1913, 2005.
107. WEIND KL, ELLIS CG, BOUGHNER DR: The aortic valve blood supply. J Heart Valve Dis 9: 1-7, 2000.
108. WESTON MW, LABORDE DV, YOGANATHEN AP: Estimation of the shear stress on the surface of an aortic valve leaflet. Ann Biomed Eng 27: 572-579, 1999.
109. WHITE JK, AGNIHOTRI AK, TITUS JS, TORCHIANA DT: A stentless trileaflet valve from a sheet of decellularized porcine small intestinal submucosa. Ann Thorac Surg 80: 704-707, 2005.
110. WILLIAMS C, LIAO J, JOYCE EM, WANG B, LEACH JB, SACKS MS, WONG JY: Altered structural and mechanical properties in decellularized rabbit carotid arteries. Acta Biomater 5: 993-1005, 2009.
111. WITTMER CR, PHELPS JA, SALTZMAN WM, VAN TASSEL PR: Fibronectin terminated multilayer films: protein adsorption and cell attachment studies. Biomaterials 28: 851-860, 2007.
112. YACOUB MH, TAKKENBERG JJ: Will heart valve tissue engineering change the world? Nat Clin Pract Cardiovasc Med 2: 60-61, 2005
113. YANG X, SHAH JD, WANG H: Nanofiber enabled layer-by-layer approach toward three-dimensional tissue formation. Tissue Eng Part A 15: 945-956, 2009.
114. YAP CH, YII M: Allograft aortic valve replacement in the adult: a review. Heart Lung Circ 13: 41-51, 2004.
115. YE Q, ZÜND G, BENEDIKT P, JOCKENHOEVEL S, HOERSTRUP SP, SAKYAMA S, HUBBELL JA, TURINA M: Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. Eur J Cardiothorac Surg 17: 587-591, 2000.
116. YILDIZ A, OZCAN F, DOGAN M, OZLÜ MF, SASMAZ A: Twenty-two years without anticoagulation with metallic heart valve. J Natl Med Assoc 98: 1348-1349, 2006.
117. ZHOU LL, MARUYAMA I, LI YH, CHENG EL, YUE B: Expression of integrin receptors in the human trabecular meshwork. Curr Eye Res 19: 395-402, 1999.
118. ZILLA P, BRINK J, HUMAN P, BEZUIDENHOUT D: Prosthetic heart valves: catering for the few. Biomaterials 29: 385-406, 2008.
119. ZISCH AH: Tissue engineering of angiogenesis with autologous endothelial progenitor cells. Curr Opin Biotechnol 15: 424-429, 2004.